tiprankstipranks
Trending News
More News >
Elite Pharmaceuticals (ELTP)
OTHER OTC:ELTP
US Market
Advertisement

Elite Pharmaceuticals (ELTP) Revenue

Compare
361 Followers

Elite Pharmaceuticals Revenue

Elite Pharmaceuticals had a revenue of 40.21M in the quarter ending Jun 30, 2025, with 25.67%. This bring the company's revenue in the last twelve months to 105.45M, Decreased 25.47%. In the fiscal year ending Dec 31, 2025, Elite Pharmaceuticals had annual revenue of 84.04M with 48.42% growth.
Revenue (ttm)
105.45M
Revenue Growth
58.70%
P/S Ratio
8.63
Revenue/Employee
$1,313,186
Employees
64
Market Cap
$724.96M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
84.04M27.42M+148.42%
Dec 31, 2024
56.63M-34.10B+0.17%
Dec 31, 2023
34.16B34.12B+105,867.56%
Dec 31, 2022
32.26M6.88M+127.11%
Dec 31, 2021
25.38M7.39M+141.05%
Dec 31, 2020
17.99M10.43M+237.76%
Dec 31, 2019
7.57M109.80K+101.47%
Dec 31, 2018
7.46M-2.18M+77.39%
Dec 31, 2017
9.64M-2.86M+77.11%
Dec 31, 2016
12.50M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis